The role of cetuximab in induction chemotherapy: Comparison of APF-C (nab-paclitaxel, cisplatin, 5-FU + cetuximab) with APF, both followed by chemoradiation therapy (CRT), in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)
| Autor: | Douglas Adkins, Jessica C. Ley, Tanya Marya Wildes, Loren S. Michel, Jason Rich, Randal Paniello, Ravi Uppaluri, Wade L. Thorstad, Hiram Alberto Gay, Kathryn Trinkaus, Toni Rachocki, Brian Nussenbaum |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Cisplatin
Oncology Cancer Research medicine.medical_specialty Cetuximab business.industry Locally advanced Induction chemotherapy medicine.disease Head and neck squamous-cell carcinoma digestive system diseases stomatognathic diseases Internal medicine otorhinolaryngologic diseases medicine Overall survival In patient business neoplasms medicine.drug Nab-paclitaxel |
| Zdroj: | Journal of Clinical Oncology. 33:6042-6042 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2015.33.15_suppl.6042 |
| Popis: | 6042 Background: Cetuximab (C) improved overall survival (OS) in patients (pts) with HNSCC when added to definitive RT or to palliative chemotherapy; however, the role of cetuximab in induction che... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|